FDA Inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site) – FDA Inspection, Jul 3, 2026
Record Details
This FDA Inspection record concerns Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site), with an inspection on July 3, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- July 3, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 5a9b37d9-43c9-4b12-8df8-bcc65712850f
Inspection Facts
- Inspection number
- 1330154
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)
- FDA Inspection 1222323 - 2023-08-29
- FDA Inspection 943139 - 2015-08-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.